Exponent Inc. Files Q3 2024 10-Q Report
Ticker: EXPO · Form: 10-Q · Filed: Nov 1, 2024 · CIK: 851520
Sentiment: neutral
Topics: 10-Q, financials, reporting
TL;DR
Exponent Inc. 10-Q filed: Q3 financials out, check Menlo Park operations.
AI Summary
Exponent Inc. filed its 10-Q for the period ending September 27, 2024. The company, headquartered in Menlo Park, CA, reported on its financial performance and business operations. Key financial data and segment information were disclosed, reflecting the company's activities in management consulting services.
Why It Matters
This filing provides investors and analysts with crucial financial and operational details for Exponent Inc., enabling informed decisions about the company's performance and future outlook.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial disclosures.
Key Numbers
- 2024-09-27 — Reporting Period End (The end date for the financial reporting period covered by the 10-Q.)
- 2023-12-29 — Fiscal Year End (The company's fiscal year concludes on this date.)
- 19930831 — Name Change Date (Date when the company's name was changed from FAILURE GROUP INC.)
Key Players & Entities
- EXPONENT INC (company) — Filer
- MENLO PARK, CA (location) — Business Address
- 20240927 (date) — Reporting Period End Date
- 8742 (industry_code) — Standard Industrial Classification
FAQ
What were Exponent Inc.'s primary reporting segments for the period ending September 27, 2024?
The filing mentions 'EngineeringAndOtherScientific' as an operating segment for the period ending September 27, 2024.
What is Exponent Inc.'s Standard Industrial Classification code?
Exponent Inc.'s Standard Industrial Classification code is 8742, categorized under SERVICES-MANAGEMENT CONSULTING SERVICES.
When did Exponent Inc. change its name from FAILURE GROUP INC?
Exponent Inc. changed its name from FAILURE GROUP INC on August 31, 1993.
What is the business address of Exponent Inc.?
The business address for Exponent Inc. is 149 COMMONWEALTH DRIVE, MENLO PARK, CA 94025.
What is the SEC file number for Exponent Inc.?
The SEC file number for Exponent Inc. is 000-18655.
Filing Stats: 4,455 words · 18 min read · ~15 pages · Grade level 19.4 · Accepted 2024-11-01 11:39:47
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share EXPO Nasdaq Global Select
Filing Documents
- expo-20240927.htm (10-Q) — 1904KB
- expo-ex31_1.htm (EX-31.1) — 12KB
- expo-ex31_2.htm (EX-31.2) — 12KB
- expo-ex32_1.htm (EX-32.1) — 6KB
- expo-ex32_2.htm (EX-32.2) — 6KB
- 0000950170-24-119886.txt ( ) — 6852KB
- expo-20240927.xsd (EX-101.SCH) — 735KB
- expo-20240927_htm.xml (XML) — 1340KB
– FINANCIAL INFORMATION
PART I – FINANCIAL INFORMATION 3 Item 1.
Financial Statements (unaudited)
Financial Statements (unaudited): 3 Condensed Consolidated Balance Sheets September 27, 2024 and December 29, 2023 3 Condensed Consolidated Statements of Income For the Three and Nine Months Ended September 27, 2024 and September 29, 2023 4 Condensed Consolidated Statements of Comprehensive Income For the Three and Nine Months Ended September 27, 2024 and September 29, 2023 5 Condensed Consolidated Statements of Stockholders' Equity For the Three and Nine Months Ended September 27, 2024 and September 29, 2023 6 Condensed Consolidated Statements of Cash Flows For the Nine Months Ended September 27, 2024 and September 29, 2023 8 Notes to Unaudited Condensed Consolidated Financial Statements 9 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 20 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 30 Item 4.
Controls and Procedures
Controls and Procedures 30
– OTHER INFORMATION
PART II – OTHER INFORMATION 31 Item 1.
Legal Proceedings
Legal Proceedings 31 Item 1A.
Risk Factors
Risk Factors 31 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 31 Item 3. Defaults Upon Senior Securities 31 Item 4. Mine Safety Disclosures 31 Item 5. Other Information 31 Item 6. Exhibits 32
Signatures
Signatures 33 - 2 -
– FINANC IAL INFORMATION
PART I – FINANC IAL INFORMATION
Financ ial Statements
Item 1. Financ ial Statements EXPONENT, INC. Condensed Consolida ted Balance Sheets September 27, 2024 and December 29, 2023 (in thousands, except par value) (unaudited) September 27, 2024 December 29, 2023 Assets Current assets: Cash and cash equivalents $ 219,708 $ 187,150 Accounts receivable, net of allowance for contract losses and doubtful accounts of $ 6,481 and $ 5,281 at September 27, 2024 and December 29, 2023, respectively 168,618 167,360 Prepaid expenses and other current assets 24,255 25,022 Total current assets 412,581 379,532 Property, equipment and leasehold improvements, net of accumulated depreciation and amortization of $ 110,828 and $ 104,011 at September 27, 2024 and December 29, 2023, respectively 72,862 75,318 Operating lease right-of-use assets 75,797 24,600 Goodwill 8,607 8,607 Deferred income taxes 54,345 53,824 Deferred compensation plan assets 113,225 101,169 Other assets 6,648 3,727 Total assets $ 744,065 $ 646,777 Liabilities and Stockholders' Equity Current liabilities: Accounts payable and accrued liabilities $ 22,646 $ 22,125 Accrued payroll and employee benefits 96,738 111,773 Deferred revenues 13,414 21,709 Operating lease liabilities 4,940 6,302 Total current liabilities 137,738 161,909 Other liabilities 4,604 3,426 Deferred compensation plan liabilities 115,527 103,398 Operating lease liabilities 75,922 21,959 Total liabilities 333,791 290,692 Stockholders' equity: Common stock, $ 0.001 par value; 120,000 shares authorized; 65,707 shares issued at September 27, 2024 and December 29, 2023 66 66 Additional paid-in capital 342,301 321,448 Accumulated other comprehensive loss Foreign currency translation adjustments ( 1,606 ) ( 2,977 ) Retained earnings 614,991 574,082 Treasury stock, at cost; 14,942 and 15,134 shares held at September 27, 2024 a